Background: Preclinical and clinical studies have utilized periprocedural parameters to optimize cryoballoon ablation dosing, including acute time-to-isolation (TTI) of the pulmonary vein, balloon rate of freezing, balloon nadir temperature, and balloonthawing time. This study sought to predict the Arctic Front Advance (AFA) vs Arctic Front Advance Pro (AFA Pro) ablation durations required for transmural pulmonary vein isolation at varied tissue depths.
| INTRODUCTION
The cryoballoon ablation (CBA) catheter has been used successfully to treat patients with atrial fibrillation (AF) by performing pulmonary vein isolation (PVI). [1] [2] [3] Traditional CBA-dosing protocols for the Arctic Front balloon (Medtronic, Inc) included multiple freeze applications with 240-to 360-second freeze durations, which were derived from preclinical animal testing, historic practices from focal cryogenic catheter usage, and typical user experience during the STOP-AF clinical trial (NCT00523978; Figure 1 and Table 1 ). 19, 20 Design improvements incorporated in the Arctic Front Advance (AFA; Medtronic, Inc) facilitated a more uniform cooling profile and enhanced energy transfer into the cardiac tissue. 21 Initially, dosing conditions established for Arctic Front were transferred to AFA; however, the observed rates of adverse events and complications (eg, phrenic nerve injury, hemoptysis, and atrioesophageal fistula formation) with the AFA suggested that there was a deeper and/or faster cooling which potentially created a higher risk of collateral tissue damage when using historic dosing practices. 10, 11, 22, 23 Consequently, studies were initiated to redefine AFA dosing parameters ( Figure 1 and Table 1 ), including (a) examining the requirement for multiple cryofreeze applications (including the bonus freeze and freeze-thaw-refreeze applications); (b) evaluating reductions in freeze duration; and/or (c) investigating intraprocedural data with regard to balloon characteristics (eg, balloon nadir temperature, acute time-to-isolation [TTI] , and balloon thaw time) that could be used to inform real-time, individualized dosing. [15] [16] [17] [18] 24 Through these studies, TTI < 60 seconds has been identified as a strong intraprocedural predictor of CBA longer-term PVI durability. 3, [15] [16] [17] [18] 24 When observed, real-time TTI of pulmonary vein (PV) signals provide a measurable parameter of acute cardiac tissue damage that can predict a durable longer-term freedom from AF recurrence. [15] [16] [17] [18] 24 Recently, the Arctic Front Advance Pro (AFA Pro; Medtronic, Inc) has been used in limited commercial release. 25 The primary differentiation between AFA and AFA Pro is an approximately 40% reduction in the length of the distal nose of the AFA Pro which may improve the ability to achieve TTI recordings and enhance balloon catheter maneuverability within the left atrium (LA). 25 Importantly, with regard to ablation dosing, the internal balloon components and specifications remain unchanged between the AFA and AFA Pro. 21, 25 Based on catheter design similarities (ie, coolant flow rates and injection port locations), the a priori assumptions of transitive freeze characteristics were evaluated between both cryoballoon catheters to examine the similarities (or differences) of freeze parameter results. In our current modeling study of AFA and AFA Pro, we examined the temporal relationship between acute TTI and the minimum freeze duration by modeling lesion formation via the cold isotherms associated with cellular electrical dormancy (TTI ED ) and cellular nonviability (TTI NV ), respectively. Ultimately, these data may better inform future designs of dosing studies by minimizing energy transfer to collateral anatomical structures which may lead to a better optimized efficacy and safety profile when treating AF patients with AFA or AFA Pro.
| METHODS
In our study, the three-dimensional computational model represents the ablation sequence of a typical cryoballoon application from the 28mm AFA or AFA Pro. The clinical applications and methods of CBA have previously been well described. [1] [2] [3] In brief, the inflated balloon is F I G U R E 1 A reduction in freeze duration is observed after the reporting of atrioesophageal fistulas, after the introduction of the Arctic Front Advance cryoballoon, and after the implementation of time-to-isolation (TTI) studies 
| Balloon-to-tissue interactions
The biophysical interactions of cold on cardiac tissue (ie, heat-energy loss) provides the foundational element for this model of lesion formation. Briefly, a circular 23-mm diameter PV with neutral angles towards the antral LA borders and uniform atrial tissue depths was generated for the model, which included neighboring tissue boundaries ( Figure 2 ). The model assumed a balloon-to-PV circumferential contact zone that was minimally 2.0 mm in width, and the model also assumed that a 30g downward force was being applied during the balloon-to-PV occlusion and subsequent freeze application. Specifically, the 2.0-mm contact zone was a theoretical minimum contact patch when assuming that a circular 23-mm diameter PV comes into contact with a 28-mm cryoballoon in an axial orientation with a 30g pushing force. The contacting LA cardiac tissue (using Pennes' bioheat which include metabolic heat generation and perfusion) and circulating blood flow (from the PV and LA chamber) both act as heat sources while the cryoballoon becomes the heat sink during the balloon ablation. Tissue temperature dynamics associated with Pennes'
bioheat are incorporated and appropriately scaled (while the tissue is in a nonfrozen temperature range). Similarly, the PV blood circulation is appropriately scaled as a heat source while in a nonfrozen state during the balloon-to-PV occlusion. With regard to LA blood circulation, the thermal modeling assumes a 12-cm/s blood flow within the LA chamber, in accordance with measurements within AF patients in sinus rhythm. 27, 28 In brief summary of this computational model, the fundamental assumed parameters are the idealized balloon-to-tissue interfacing boundaries and the thermodynamic heat (source and sink) exchanges, which then predict a progression of cold through the cardiac tissue and a resulting cellular response (and subsequent lesion formation in the manner of a PVI).
| Cellular response to heat-energy loss
As N 2 O undergoes a liquid-to-gas phase shift (under Joule-Thomson conditions within the cryoballoon); heat from the surrounding cardiac tissue is withdrawn, and a cold isotherm propagates outward from the balloon-to-tissue interface as a function over time. 26 Specifically, our model focuses on two isothermal processes that have been determined to elicit a cellular response, which are later indicative of critical steps in the lesion formation after CBA. The first critical isotherm (23°C) represents the point at which myocardial cells exhibit a significant decline and ultimate cessation of electrophysiological activity (ie, electrical dormancy; TTI ED ). [29] [30] [31] For this study, it was modeled that when this isotherm achieved circumferential transmurality the electrical PV potentials became acutely isolated, which was denoted as the time-to-isolation for electrical dormancy (TTI ED ). TTI ED in this model represented acute TTI which is typically observed in the clinical electrophysiology laboratory during cryoballoon ablation of a PV. More specifically, it is the point at which PV electrical potentials become disassociated with the LA chamber during cryoablation. The second critical isotherm during a cryoablation (−20°C) represents the point at which myocardial cells reach nonviability. 32, 33 In our current modeling study, the time-to-isolation for nonviability (TTI NV ) was denoted and modeled as the critical point whereby the isotherm achieves a circumferentially transmural temperature of −20°C and the cells become irreversibly nonviable.
TTI NV in this model represented the minimum freeze duration required for permanent cellular damage. Ultimately, the computer model will determine the spatial range of cold propagation during F I G U R E 2 Schematic representation of the thermal boundary conditions and primary domains TTI ED and TTI NV (Figure 3) . Further, the model will derive a response formula between TTI ED and TTI NV timing of events across different cardiac tissue thicknesses ( Figure 4 ).
| Tissue depth
The distribution of temperature decay is not uniform from the cryoballoon surface onto the contacted cardiac tissue. 34 Specifically, the isotherm propagates into the cardiac tissue maximally at the center-point of balloon-to-tissue contact, and the coldest tempera- Consequently, it was critical to conduct computational modeling simulations with varying degrees of cardiac tissue depth to account for the engineered balloon variability (eg, balloon size and catheter models) and the human cardiac anatomy variability. 35 Regarding LA and PV anatomies, a previous imaging study determined that the LA wall thickness in patients undergoing PVI had an average thickness of 1.89 ± 0.48 mm (range, 0.5-3.5 mm). 35 This information drove the primary assumed variable within the model, which was LA tissue thickness near the PV. In our model, Simply, the AFA Pro catheter was built on the AFA platform, with the same internal balloon components and specifications. 25 The primary difference between the two cryoballoon catheters is a 40% reduction in distal-tip length from AFA to AFA Pro (13.5 vs 8 mm). This change in AFA Pro was designed to increase maneuverability within the LA and increase the probability of recording PV potentials with the Achieve Inner-lumen Mapping Catheter (Medtronic, Inc). 25 Consistent between both balloons, the injection tube coil remains 21.5-mm distal to the thermal-couple location, and thus, the N 2 O spray pattern and return gas temperature recordings are unchanged between AFA and AFA Pro. 25 Most importantly, there is little expected thermodynamic change that is "a priori" predicted between the two balloon catheters; however, the purpose of utilizing the two cryoballoon systems was to test the importance of homogeneity within the balloon internal specifications vs discrete changes to the external balloon components.
| RESULTS
Our computational model tracks change in temperature over time and distance. With the known temperature changes through tissue depths during cryoablation, the output solves for the time required for the TTI ED and TTI NV isotherms to reach full circumferential transmurality for the defined tissue depth(s).
| Establishment of the computational model
To examine the computational model accuracy, the mesh convergence study performed for each of the tissue depths resulted in a variance of ±8% to ensure the results were independent of mesh size.
The cylindrical model dimensions were identified to be sufficiently large as to not influence the results. continued to progress deeper into the cardiac tissue (Supporting Information Video S1). Of note, in our computational model, the progression of the cold isotherms effect the blood pool that was in contact with the balloon (as well as the tissue that is in direct contact). In our model, the ice cap within the pulmonary vein forms within 35 seconds and will continue to grow at a decaying speed. Tables 2 and 3 were similar with regard to TTI NV with no more than 4% variance at 5.0 mm between the two balloons when establishing cellular nonviability.
| Relationship between TTI ED and TTI NV
As the tissue depth increases beyond 2.0 mm in the computational model, the time separating TTI ED and TTI NV expanded. Figure   4A and (Figures 3 and 4) . The data confirms that AFA and AFA Pro shared similar thermodynamic characteristics, as the internal components remained unchanged between the two balloon catheters. 25 The results of this computational modeling were functional formulas (specifically for AFA and AFA Pro; Figures 3 and 4 24 Specifically, when TTI ED was obtained in under 60 seconds, physician users have developed algorithms that continued the freeze application for a total ablation time of about 180 seconds. 15, 24 More importantly, these shortened single-freeze dosing strategies using TTI ED were found to have robust longer-term efficacy in prospective studies. 24 Last, there has not been a large randomized controlled clinical study to establish a set dosing standard, and the larger variety of user habits may make such a study impossible and/or impractical (eg, differences in patient selection, preprocedural imaging, sedation, over-the-wire delivery, occlusion testing, anatomical ablation strategy, freeze termination rules, etc). Consequently, the important work done in computer modeling, animal studies, clinical trials, and real-world clinical dosing algorithms are the only avenues to set-up common and/or wellpracticed dosing guidance. 1, 2, 15, 18, 21, 24 
| Previous modeling and experiments
Similar in vivo experiments have been conducted that measure the cryoballoon freeze characteristics under different study design parameters. 36, 37 Specifically, direct surgical attachment of thermocouples into cardiac and surrounding tissues in canine models have measured time, temperature, and distance relationships during a cryoballoon freeze. 36, 37 In general, our computational modeling data agree with these data, albeit with small differences (warmer temperatures in the canine models) with regard to the nadir temperature ranges observed within cardiac and surrounding tissues. 36, 37 These discrepancies between our model and the Specifically, it demonstrates the positive nonlinear relationships of cold temperature propagation over a distance through cardiac tissue (with regard to TTI ED and TTI NV ). Last, it must be acknowledged that a previous attempt to model the thermodynamic properties of the cryoballoon has been reported. 38 However, without direct knowledge of the proprietary cryoballoon specifications, this previous study (from an independent research group) was limited in the predictive power of the computational model.
| Real-world usage of time-to-isolation
In clinical practice and study design, TTI (aka, time-to-effect) has been used to denote TTI ED , and the additional freeze duration (time beyond TTI ED ) has allowed for additional temperature decline within the targeted cardiac-ablation zone until TTI NV is achieved. 15, 24 In our computational model, TTI ED was achieved in about 60 seconds when the cardiac tissue was 3 mm at the targeted site of ablation.
Furthermore, TTI NV was obtained within 180 seconds when the freeze duration was extended at this hypothetical depth of ablation. For cardiac tissue thicknesses of 0.5 through 3 mm the response interaction was mostly linear (Figures 3 and 4) ; however, at tissue depths of 4 and 5 mm, the additional freeze time to achieve TTI NV was prolonged.
Our exponential freeze-response curve is similar to the real-time cryoablation measurements recorded using magnetic resonance imaging (MRI). 39 Specifically, a study by Lichter et al 39 determined by MRI that the normalized area of freeze increased rapidly from the start of cryoablation through 120 seconds, and a further increase in area of freeze was observed at 180 seconds (although the latter had a diminished rate of freeze area increase). Last, very little continued growth of the freeze area was observed between 180 and 240 seconds by MRI measurements. 39 This very slow rate of increase beyond the initial 120 seconds explains the very prolonged TTI NV at higher depths.
Not surprisingly, empirical clinical dosing has arrived at a similar dosing paradigm well before our modeled computations. Specifically, it is common to ablate a PV for an overall duration of 180 seconds when TTI ED is less than 60 seconds. 3 Our model determined TTI ED could be achieved in 63 seconds and TTI NV in 160 seconds when the cardiac tissue was 3-mm thick. Furthermore, several clinical cryoballoon dosing algorithms have based the success parameter of acute PVI on the ability to obtain TTI within and around 60 seconds. [15] [16] [17] [18] 24 More specifically, the usage of TTI + 120 seconds is a strategy used in previous studies that have evaluated dosing algorithms and longerterm PVI durability. 3, 15, 24 Given that our computational values are true (at a "normal" cardiac tissue depth of about 3 mm); a "good" freeze GETMAN ET AL.
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attempt with the cryoballoon should achieve TTI ED within approximately 60 seconds (when PV potentials are viewable). When TTI ED is not achieved in 60 seconds, an abort of the freeze and repositioning of the cryoballoon may be a better dosing strategy. 24 However, these aforementioned dosing algorithms must consider cardiac tissue depths at known anatomical structures. 31 As an example, it would be expected that TTI ED is extended when the cryoballoon is ablating along a thickened cardiac anatomy such as the ridge between PV and left atrial appendage. Ultimately, our computational model data might further progress dosing strategies and algorithms that continue to attempt to shorten the cryoablation freeze duration. 40 
| The future of computational model data usage
Our current study precisely examined only the relationship between 
| LIMITATIONS
The validity of computational modeling is foundational to the assumed variables and parameters that were captured in the mathematical inputs. In our model, the PV was perfectly circular with consistent (and discrete) depths of tissues having homogeneous tissue characteristics and idealized coaxial cryoballoon positioning, assuming perfect occlusion. While these assumptions were "built-in"
to manage the complexity of the model; it is recognized that there is variability and heterogeneity in the previous real-world parameters.
Further, our computational model assumes a decay input to Pennes' bioheat equation between 37°C and 23°C, the temperature at which no heat is generated by tissue. Similarly, localized vascular perfusion was assumed to slow between 37°C and become negligible at 0°C. Last, our computational modeling was limited to clinically relevant cardiac tissue depths and clinically relevant usage conditions of the cryoballoon. Of note, we did not model tissue depths to 10 mm, and we did not consider the extended cryoballoon freeze duration to achieve a 10-mm freeze depth. While a theoretical computational model can calculate the above parameters, we made every attempt to restrain modeling assumptions and usage conditions to clinically relevant real-world usage parameters.
| CONCLUSION
The computational model predicts a minimum duration of freeze (TTI NV ) needed to obtain a durable and transmural lesion when acute TTI of the PV is observed (TTI ED ). This can be used clinically to titrate CBA rather than using empiric freeze times-minimizing procedure durations and potentially reduce collateral tissue damage. The computational model of CBA can be further used for future clinical investigations to optimize CBA for different anatomies or targeting beyond the PV anatomy.
